---
figid: PMC4136419__nihms603930f1
figtitle: Targeting the B cell receptor signaling pathway in B lymphoid malignancies
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4136419
filename: nihms603930f1.jpg
figlink: /pmc/articles/PMC4136419/figure/F1/
number: F1
caption: After ligation of BCRs, Src kinases phosphorylate ITAMs, where SYK binds
  and is also activated by phosphorylation. SYK then passes the signal further downstream
  by phosphorylating SLP65, BTK, and PLCγ2. Furthermore, the PI3K and MAPK signaling
  pathways are activated. Finally, BCR receptor stimulation leads by sequential phosphorylation
  events to activation of MYC, NF-κB and NFAT.
papertitle: Targeting the B cell receptor signaling pathway in B lymphoid malignancies.
reftext: Maike Buchner, et al. Curr Opin Hematol. ;21(4):341-349.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9635673
figid_alias: PMC4136419__F1
figtype: Figure
redirect_from: /figures/PMC4136419__F1
ndex: 240c4478-ded7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4136419__nihms603930f1.html
  '@type': Dataset
  description: After ligation of BCRs, Src kinases phosphorylate ITAMs, where SYK
    binds and is also activated by phosphorylation. SYK then passes the signal further
    downstream by phosphorylating SLP65, BTK, and PLCγ2. Furthermore, the PI3K and
    MAPK signaling pathways are activated. Finally, BCR receptor stimulation leads
    by sequential phosphorylation events to activation of MYC, NF-κB and NFAT.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - LYN
  - BTK
  - BLNK
  - KRAS
  - HRAS
  - NRAS
  - SYK
  - RASGRP3
  - PLCG2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K1
  - MAP2K2
  - CARD11
  - MAPK3
  - MAPK1
  - BCL10
  - PRKCB
  - MALT1
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MYC
  - NFKB1
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - CD19
  - Fostamatinib
  - Ibrutinib
  - PRT062607
  - phenothiazines
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
